Current treatments: patients with chronic inflammatory diseases, including ulcerative colitis & Crohn’s Disease are treated with anti-inflammatory agents that temporarily control the symptoms of the disease but also have major toxicities, including increased risk of infections and cancers.
Our approach: Athos has developed an innovative computational process based on machine learning algorithms that identifies novel and safe drug/gene targets for individual patients.